Medibank Private Ltd. Apr 02

  • ID: 2026331
  • April 2002
  • Standard & Poors
1 of 3

The ratings assigned to Medibank Private Ltd. (Medibank) reflect the fund's dominant market position, strong earnings, and solid capitalization. Moderating factors include a relatively high level of growth assets in the context of the very short-tail nature of underlying liabilities, poor investment performance in 2001, and restricted financial flexibility. Medibank, the government-owned private health insurer, holds the leading market position in the Australian private health insurance sector. It increased its market share of contribution income to 29.4% in 2001 from 27.0% in 2000, following the surge in health fund membership associated with the government initiatives in 2000. Medibank's competitive advantage is its strong brand name and nationwide distribution network, developed through government ownership and its historical association with other government...

Companies mentioned in this report are: Medibank Private Ltd.
Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

Medibank Private Ltd.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.